SEARCHING
The FNR is pleased to announce the opening of the fourth PRIDE Call, with a deadline of Wednesday, 20 October 2021, 14:00 CET. Through the PRIDE programme, the FNR awards block PhD grants to Doctoral Training Units (DTU) in Luxembourg.
The FNR and the Luxembourg Ministry of Agriculture, Viticulture and Rural Development (MAVDR) have joined forces to put forward a call for proposals to support policy making and to help the decision-making process. The Call is now open, with a deadline of 15 October 2021. The Q&A from the info session is now available.
The FNR has published its annual report for 2020, a year which was obviously marked by the COVID-19 crisis, but which also saw the funding of 299 research projects for a committed amount of 97.06 MEUR.
The FNR is pleased to announce the FNR Open Access Fund is now open. Deadline for applications is Wednesday, 20 October 2021, 14:00 CET.
The FNR is pleased to announce that the third edition of SciCom Luxembourg (previously known as Science Communicator Networking Event) will take place on Thursday, 30 September 2021 (afternoon) as an online event.
Glioblastoma is the most aggressive form of brain tumours in adults. The incidence is about 4 per 100.000 people and the average survival after diagnosis is about 14 months with current treatments. The tumour’s location represents a major challenge – few drugs make it past the blood brain barrier. Researchers are working on designing a novel kind of drug that could help do just that.
Nobody is untouched by environmental chemical pollution, but most are unaware of how they are exposed, what to, and the possible health consequences. With over 350,000 registered chemicals in use, an important first step towards assessing their environmental impacts is to make chemical information more machine-readable and open. Environmental Cheminformatics is on the case.
Melanoma is a rare type of skin cancer, but it is the deadliest type – and incidence is on the rise. Metastatic melanoma has seen a rapid emergence in drug resistance: After a few months, treatment stops working and tumours begin to grow again. Molecular biologists are working to understand why this happens.
A rapid increase in both life expectancy and global population size has led to a rise in the prevalence of chronic ageing-associated diseases. Brain and heart age-associated diseases including hypertension, stroke, heart failure, Alzheimer’s and Parkinson’s diseases are leading causes of mortality and disability worldwide. Researchers are working on much-needed ways to predict these diseases.
